The Patent Finder

Terms ending in 2029

Oncotherapy Science, Inc.

Every in-force patent on Oncotherapy Science, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,378,081Antibodies That Specifically Bind to Abeta Oligomers and Uses Thereof
In force
 · High confidence
Oncotherapy Science, Inc.In forceHigh confidence
US 8,674,059Colon Cancer Related Gene TOM34
In force
 · High confidence
Oncotherapy Science, Inc.In forceHigh confidence
US 9,193,765Melk Epitope Peptides and Vaccines Containing the Same
In force
 · High confidence
Oncotherapy Science, Inc.In forceHigh confidence
US 9,675,680Melk Epitope Peptides and Vaccines Containing the Same
In force
 · High confidence
Oncotherapy Science, Inc.In forceHigh confidence
US 9,132,176RAB6KIFL/KIF20A Epitope Peptide and Vaccines Containing the Same
In force
 · High confidence
Oncotherapy Science, Inc.In forceHigh confidence
US 8,435,749ANTI-CDH3 Antibodies Labeled with Radioisotope Label and Uses Thereof
In force
 · High confidence
Oncotherapy Science, Inc.In forceHigh confidence
US 9,017,669ANTI-CDH3 Antibodies and Uses Thereof
In force
 · High confidence
Oncotherapy Science, Inc.In forceHigh confidence
US 8,541,546Wdrpuh Epitope Peptides and Vaccines Containing the Same
In force
 · High confidence
Oncotherapy Science, Inc.In forceHigh confidence
US 9,745,343Method of Inducing an Immune Response by Administering Wdrpuh Epitope Peptides
In force
 · High confidence
Oncotherapy Science, Inc.In forceHigh confidence
9 of 9 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited